 |
| Gadolite® Oral Suspension |   |
| |
|
An oral suspension of synthetic crystalline aqueous orange-flavored MRI contrast agent to enhance delineation of the bowel. Gadolite contains gadolinium, a lanthanide metal with paramagnetic characteristics. The toxic Gd is bound to become inert, along with water, inside a zeolite crystalline lattice structure. Gadolite gives a bright signal, and provides improved definition of the gastrointestinal tract from adjacent tissues.
Pharmacyclics receives an approvable letter from the FDA for Gadolite® Oral Suspension and in the United Kingdom an European marketing agreement signed with E-Z-Em, Ltd. in Dec. 1996.
|
|
Drug Information and Specification |
| NAME OF COMPOUND |
Gadolinium zeolite, Gadolinium chloride hexahydrate |
| DEVELOPER |
Pharmacyclics, Inc. |
| CENTRAL MOIETY |
Gd2+ |
| CONTRAST EFFECT |
T1, Predominantly positive enhancement |
| RELAXIVITY |
Paramagnetic |
| PHARMACOKINETIC |
Gastrointestinal |
| OSMOLALITY |
|
| CONCENTRATION |
|
| DOSAGE |
|
| PREPARATION |
Oral suspension |
| INDICATION |
Bowel marking |
| DEVELOPMENT STAGE |
For sale |
| DISTRIBUTOR |
See below |
| PRESENTATION |
Suspension |
| DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT! |
|
|
Distribution Information |
| TERRITORY |
TRADE NAME |
DEVELOPMENT
STAGE |
DISTRIBUTOR |
USA
Canada
Mexico
EU |
Gadolite® Oral Suspension |
for sale |
E-Z-EM |
|
| |
 |
|
 Further Reading: |
Basics:
|
|
News & More:
| | | | |
] and 2 definitions [
]
bottom
(.pdf)
Random Page
top
